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SAR thresholds for electromagnetic exposure using functional thermal
dose limits
Fatemeh Adibzadeh, Margarethus M. Paulides and Gerard C. van Rhoon
Department of Radiation Oncology, Hyperthermia Unit, Erasmus MC - Cancer Institute, Rotterdam, The Netherlands
ABSTRACT
Background and purpose: To protect against any potential adverse effects to human health from
localised exposure to radio frequency (100 kHz–3GHz) electromagnetic fields (RF EMF), international
health organisations have defined basic restrictions on specific absorption rate (SAR) in tissues. These
exposure restrictions incorporate safety factors which are generally conservative so that exposures that
exceed the basic restrictions are not necessarily harmful. The magnitude of safety margin for various
exposure scenarios is unknown. This shortcoming becomes more critical for medical applications where
the safety guidelines are required to be relaxed. The purpose of this study was to quantify the magni-
tude of the safety factor included in the current basic restrictions for various exposure scenarios under
localised exposure to RF EMF.
Materials and methods: For each exposure scenario, we used the lowest thermal dose (TD) required
to induce acute local tissue damage reported in literature, calculated the corresponding TD-functional
SAR limits (SARTDFL) and related these limits to the existing basic restrictions, thereby estimating the
respective safety factor.
Results: The margin of safety factor in the current basic restrictions on 10g peak spatial average SAR
(psSAR10g) for muscle is large and can reach up to 31.2.
Conclusions: Our analysis provides clear instructions for calculation of SARTDFL and consequently quan-
tification of the incorporated safety factor in the current basic restrictions. This research can form the
basis for further discussion on establishing the guidelines dedicated to a specific exposure scenario, i.e.
exposure-specific SAR limits, rather than the current generic guidelines.
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Introduction
To protect against any established health effect of electro-
magnetic (EM) exposure, international safety organizations,
such as ICNIRP and IEEE, have defined basic restrictions on
maximum exposure of humans to electromagnetic fields
(EMF) [1,2]. Based on these guidelines at radio frequency (RF)
range of EMF (100 kHz–3GHz), exposure should not result in
peak spatial average SAR (psSAR) that exceeds 10W/kg as
averaged over any 10 g of tissues (psSAR10g). From here on
we shall refer to this value as SARBR. This level applies to
exposure of persons in occupational environments, i.e.
trained adults under controlled conditions. The basis of these
guidelines is to limit tissue heating below a conservative
safety threshold of 1 C.
To provide a large margin of safety, the local SAR safety
threshold is lowered by a conservative safety factor.
Although not quantified, it is believed that the safety factor is
at least a factor of 10 and probably considerably more if the
remarkable thermal tolerance in human studies is accepted as
generally valid [2]. The selection of the incorporated safety
factor in the current guidelines was based on informed
expert opinion rather than a rigorous quantitative process.
The magnitude of safety factor for any given localised
exposure scenario is unknown.
The above shortcoming becomes more critical for some
applications where the safety guidelines should be relaxed to
achieve better therapeutic or diagnostic results [3–5]. For
instance, in medical imaging or therapy taking more risk is
permissible if this provides a better diagnosis or therapeutic
effect. We recently performed dose–effect relations studies
and showed that exceeding the SARBR by up to at least 14
(brain [6]) and 10 (eyes [7]) times during hyperthermia (HT)
cancer treatment in the head and neck region, showed no
indication for any serious acute effect for any of the treated
patients. In view of these publications and to align the basic
SAR restrictions with the current practice, medical applica-
tions should have added flexibility in safety guidelines by
taking a much smaller safety factor. This approach has been
applied to some extend for magnetic resonance imaging
(MRI) application in the third edition of the IEC standards [8]:
safety guidelines on the maximum value for the local
psSAR10g are doubled for the first level operation mode.
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Therefore, there is a need to quantify the incorporated safety
factors more precisely and to relax the limits on EM exposure
accordingly.
The main objective of the current study was to quantify
the incorporated safety factor in the current ICNIRP and IEEE
basic restrictions for various localized RF exposure scenarios.
To this end, using previously published data [9], we first
translated the functional thermal dose (TD) required to
induce acute local tissue damage into corresponding TD-
based functional SAR limits (SARTDFL). The ratio between
these SARTDFL values and SARBR, is defined as safety factor.
Secondly, we performed a sensitivity study to assess the
changes in the calculated SARTDFL due to exposure parame-
ters. Thirdly, we evaluated our results by comparing the
SARTDFL to SAR levels in realistic clinical situations. Finally, we
proposed a simple instruction to calculate SARTDFL limit for
any given exposure scenario.
Methods
In the current study, we calculated the SARTDFL necessary to
induce heating up to Tthresh, i.e. the corresponding steady
state temperature of the lowest TD that results in tissue dam-
age in the particular tissue type [9]. This was calculated for
the centre of a spherical target within a 37 C medium
(Figure 1). This target mimics a hotspot in tissue, induced by
localized exposure to RF EMF.
As a first step, we translated the TD to Tthresh for tissues
used in our previous study [9] (Table 1) based on the defin-
ition of cumulative equivalent minutes at 43 C (CEM43 C).
Secondly, we calculated the value of SARTDFL based on the
Pennes bioheat equation (PBE) and compared its value within
various tissues. Thirdly, we assessed the sensitivity of SARTDFL
due to changes in the target diameter (as a result of changes
in exposure frequency), exposure duration and thermal tissue
properties for muscle. Muscle was selected as thermal hot-
spots occur most commonly in this tissue during medical
applications such as HT and MRI, with a frequency range: ca.
1–1000MHz [10] and literature values are more abundant.
We calculated the SARTDFL values for target diameters of 20,
15, 10, 5, 2, 1 and 0.5 cm using various databases containing
basal and thermoregulated tissue properties [11–14].
To evaluate the influence of exposure duration on the
results, we compared the SARTDFL for exposure duration of
60, 30, 15 and 5min in targets of 20, 5, 2 and 0.5 cm
diameter.
Finally, we evaluated our results by comparing the calcu-
lated SARTDFL values in the current study with simulated SAR
values inside a realistic anatomical model under exposure of
RF EMF from head and neck HT treatment and 1.5 T MRI
imaging. The simulations were performed using SEMCAD X
(v.14.8.4, SPEAG, Zurich, Switzerland) and validated by match-
ing to the experimental data [10,15].
CEM43 C TD
Thermal dose is usually expressed in units of cumulative
equivalent minutes at 43 C (CEM43 C) [16–18]. The
CEM43 C dose model expresses the thermal load on living
tissues by estimating the equivalent induced thermal stress
in minutes at 43 C. We translated the reported tissue-specific
CEM43 C thresholds to Tthresh based on the CEM43 C defin-
ition assuming a constant temperature over the duration of
exposure (Table 1).
CEM43C ¼
Xn
i¼1
tiR
ð43TÞ (1)
Where CEM43 C is the cumulative number of equivalent
minutes at 43 C, ti is the i-th time interval, R is related to the
temperature dependence of the rate of cell death
(R(T< 43 C)¼ 1/4, R(T> 43 C)¼ 1/2) and T is the average
temperature during time interval ti.
Pennes bioheat equation
Pennes bioheat equation (PBE) [19] is often used by research-
ers for evaluating RF-induced temperature distributions and
heating dynamics in perfused or non-perfused tissues.
qc
oT
ot
¼ r: krTð Þ þ qQþ qSAR qbcbqx T  Tbð Þ (2)
Here, T is the tissue temperature, t is the time, SAR is the
specific absorption rate, x is the perfusion rate, q is the dens-
ity of the medium the volume, c is the specific heat capacity, k
is the thermal conductivity, Q is the metabolic heat generation
rate. The subscript b denotes a blood property, respectively.
Figure 1. Main image: Modelled hotspot-mimicking a spherical target inside a
tissue at 37(C). Inset images: Induction of temperatures up to Tthresh at centre
of the sphere, and the corresponding SARTDFL.
Table 1. Translation of the lowest tissue-specific CEM43 C doses that result in
thermal tissue damage in large animals (cat, dog and pig) and humans, to the
corresponding temperature for exposure durations of 60, 30, 15 and 5min.
According to CEM43 C definition (Equation (1), the value of Tthresh depends
on the exposure duration.
Tthresh (C)
Tissue
CEM43 Ca
(min)
t¼ 60
(min)
t¼ 30
(min)
t¼ 15
(min)
t¼ 5
(min)
Brain 7.5 41.5 42.0 42.5 43.6
Spinal cord 30 42.5 43.0 44.0 45.6
Peripheral nerve 45.5 42.8 43.6 44.6 46.2
Skin 288 45.3 46.3 47.3 48.8
Esophagus 120 44.0 45.0 46.0 47.6
Liver 9.9 41.7 42.2 42.7 44.0
Bladder 90.5 43.6 44.6 45.6 47.2
Prostate 30.0 42.5 43.0 44.0 45.6
Muscle 60.0 43.0 44.0 45.0 46.6
Fat 240 45.0 46.0 47.0 48.6
aDerived from [9] and using data summarised in reviews on thermal thresh-
olds for tissue damage [31,32].
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In the current study, we used the Partial Differential
Equations (PDE) toolbox in MATLAB (MathWorks, Natick) to
solve the PBE. The calculated SAR is directly dependent on
the tissue property values as inputs for PBE. The dielectric
parameters were taken from the database of Gabriel [20,21].
The thermal parameters were derived from various databases
as shown in Table 2.
Basal and thermoregulated tissue properties
If we compare thermal parameter values across several data-
bases, we find small differences for density, specific heat, and
thermal conductivity. For perfusion, however, differences are
large because the literature values for blood perfusion are
generally at resting condition (baseline temperature: 37 C),
while values at high temperatures are completely different
due to thermoregulatory response of tissues under thermal
stress. For local hotspots above 20W/kg psSAR10g, thermo-
regulated local perfusion is a major HT response mechanism
[22] that largely determines RF-induced tissue temperature
increase [23]. Thermoregulatory processes show typical
response times on the order of 10min [24,25]. In the current
study, we did not consider the transient effect of thermoregu-
lation, i.e. the values of parameters at steady state were
always used.
Impact of local thermoregulation on RF-induced heating
was analysed using databases and models of both basal and
thermoregulated perfusion, as follows:
Basal perfusion
 Literature summary by McIntosh: McIntosh et al. standar-
dised tissue thermal parameters by documenting 140 key
papers and books and developed a database of thermal
properties for around 50 human tissues [11].
 IT’IS Foundation tissue database: IT’IS foundation took an
inclusive approach and incorporated all studies with vary-
ing approaches and degrees of accuracy—after eliminating
studies with major flaws—to increase the parameter sam-
ple size used. This database provides the average values
and information about the variability of parameters [12].
Thermoregulated perfusion
 Sigma Hyperplan tissue database: These values are pro-
vided by the HT treatment planning system HyperPlan
and derived from the clinical application of deep pelvic
HT with the Sigma-60 applicator. Typical values of thermal
conductivity and perfusion are listed in [26], and empiric-
ally obtained values created by HT model-treatment com-
parison are found in [13,27].
 Temperature-dependent model by Lang: Lang et al. [14]
employed a temperature-dependent blood perfusion
model based on preclinical measurement data of [28] to
improve the classical bio-heat term in PBE, which
assumed a constant-rate blood perfusion within each tis-
sue [14]. For each exposure scenario, we calculated the
perfusion value based on Lang model using the corre-
sponding Tthresh in Table 1.
 Erasmus MC database: We calculated the effective perfu-
sion for tumour, muscle and fat from the measurement
data obtained during deep head and neck HT treat-
ments of nine patients that had interstitial catheters in
the target region (unpublished research). The effective
perfusion was reconstructed based on the thermal
washout technique from temperature decay measure-
ments [29,30].
In summary, we assume that at resting condition, the
databases of McIntosh and IT’IS are more reliable because
they are based on a large number of studies. Under ther-
mal stress and other conditions that may increase perfu-
sion, the databases/models of Erasmus MC, Hyperplan and
Lang provide more reliable data as they take thermoregu-
lated perfusion into account. In the current study, we took
the Erasmus MC properties and exposure duration of
60min (steady state exposure duration for mild HT applica-
tion) as reference. For each calculation, we used the ther-
mal parameters (specific heat capacity, thermal
conductivity, density and blood perfusion) of one database.
In case that a database, e.g. Lang and Erasmus MC, does
not contain all parameters we took the missing parameters
from the IT’IS database.
Table 2. Thermal tissue properties based on McIntosch [11], IT’IS [12], hyperplan [13], lang [14] and erasmus MC databases.
Specific heat capacity,
c (J/kg/C)
Thermal conductivity,
K (W/m/C) Density, q (kg/m3) Blood flow, x (ml/min/kg)
Tissue Mc IT’IS Hyper Mc IT’IS Hyper Mc IT’IS Hyper Mc IT’IS Hyper Lang Erasmus
Bladder 3514 – 3500 0.47 – 0.60 1132 – 1000 30 – 150 300 –
Brain 3653 3630 – 0.51 0.51 – 1046 1046 – 530 559 – – –
Eye cornea 3615 3615 – 0.50 0.54 – 1174 1051 – 0 0 – – –
Fat 2301 2348 3500 0.19 0.21 0.21 909 911 900 30 33 200 48 309
Kidneys 3786 3763 3500 0.54 0.53 0.58 1072 1066 1000 3960 3795 4000 4000 –
Liver 3507 3540 3500 0.51 0.52 0.64 1088 1079 1000 420 860 1000 1000 –
Muscle skeletal 3514 3421 3500 0.51 0.49 0.64 1102 1090 1000 30 37 300 180–240 457
Nerve 3452 3613 – 0.46 0.49 – 1112 1075 – 160 160 – – –
Skin 3310 3391 – 0.41 0.37 – 1114 1109 – 60 106 – 275a –
Spinal cord 3452 3630 – 0.46 0.51 – 1112 1075 – 160 160 – – –
Esophagus – 3500 – – 0.53 – – 1040 – – 190 – – –
Rectum – – – – – – – – – – – – – –
Prostate – 3760 – – 0.51 – – 1045 – – 394 – – –
aDerived from [33].
1250 F. ADIBZADEH ET AL.
Results
Tthresh: steady-state temperature approximation in lieu
of TD
Table 1 includes the translated Tthresh values from the
reported tissue-specific CEM43 C TDs based on the CEM43 C
definition (Equation (1). It indicates that the value of Tthresh
depends on the exposure duration, hence, the same value of
TD for a specific tissue may be obtained at high temperature
for a short exposure and at low temperature for a long
exposure.
Functional SAR limits SARTDFL: influence of target
diameter, exposure duration and tissue thermal
parameters
Figure 2 shows the calculated SARTDFL for various available
tissues in Table 1. The figure indicates that muscle has the
lowest SARTDFL value among tissues, when applying the basal
tissue property databases which are more comprehensive
compared to thermoregulated databases. It also indicates
that the SARTDFL increases significantly if the thermoregu-
lated perfusion is applied. The maximum variation in calcu-
lated SARTDFL is seen in muscle, which is 10-fold greater
using parameters from Erasmus MC, compared to SARTDFL
estimates using the McIntosh database.
Figure 3 shows the impact of target diameter and ther-
mal tissue parameters on the calculated SARTDFL in the
muscle. It demonstrates the rapid increase in SARTDFL with
decreasing target diameter, i.e. SARTDFL increases 180-fold
as spherical hotspot region decreases from 20 cm to 0.5 cm
diameter. The figure also indicates that the variations in
the calculated SARTDFL due to the differences in thermal
tissue properties among various databases are larger for
bigger targets, where the tissue blood perfusion is the
dominant parameter, and decreases in small targets, where
thermal conduction dominates (Figure 3). The maximum
variation in the calculated SARTDFL due to differences in
thermal parameters over various databases is in a target of
20 cm diameter, with a 12.5-fold increase using thermo-
regulated perfusion (Erasmus MC database) vs. basal perfu-
sion (McIntosh database).
Figure 4 shows the impact of exposure duration on
the calculated SAR threshold. It indicates that by reduc-
tion of exposure duration, the calculated SARTDFL in tar-
gets increases, which is caused by the higher
thresholds of temperature increase in tissues, i.e. accord-
ing to the CEM43 C definition, shorter exposure dur-
ation requires higher temperature for the same
CEM43 C TD (Equation (1). This increase is more pro-
nounced in larger targets than in small targets. For
exposure duration less than
About 10min (thermoregulatory response time) only the
basal thermal tissue properties from the McIntosh database
were applied. The calculated SAR limit for muscle using
McIntosh database increases by 10-fold by reducing the
exposure duration from 60 to 5min in a target of 20 cm
diameter. This increase is lower for smaller targets.
Validation of the SAR limits using clinical conditions
To validate our results, we compared the calculated SARTDFL
with the SAR values that have been assessed based on com-
plicated numerical simulation software. Hereto, we calculated
and compared the SARTDFL with the simulated SAR in ana-
tomical human models under exposure to RF EMF from HT
treatment and 1.5 T MRI imaging. In our previous study we
used detailed numerical EM and thermal simulations to
Figure 2. Comparison of SARTDFL among various tissues after 60min exposure,
using various tissue property databases. The SARTDFL values were calculated
assuming that the target is uniformly heated.
Figure 3. Impact of target diameter on the SARTDFL in muscle using various
databases for thermal tissue properties. The SARTDFL values were calculated for
exposure duration of 60min.
Figure 4. Impact of exposure duration on the SARTDFL after 60, 30, 15 and
5min exposure in targets of 20, 5, 1 and 0.5 cm diameter in muscle. The results
are calculated for only basal (McIntosh) and thermoregulated (Erasmus MC) per-
fusions, considering 10min delay in thermoregulatory process of tissue, i.e.
there is no thermoregulated perfusion for exposure duration<10min.
INTERNATIONAL JOURNAL OF HYPERTHERMIA 1251
assess the maximum induced SAR and temperature in
patients during 60min of HT treatment in the head and neck
region [7]. The results showed that psSAR10g¼191.5W/kg is
required to increase the temperature by 6 C in 10 g of
muscle (equivalent to a spherical target of 2.6 cm diameter).
The calculated SARTDFL for muscle in a target of 2.6 cm using
thermoregulated Erasmus MC database is 218.3W/kg.
In addition, Murbach et al. [34] reported that performing MRI
in the first level operating mode (OM) afforded psSAR10g val-
ues as large as 62W/kg. Their results show that such psSAR10g
value in a healthy volunteer may result in a local temperature
increase of 4 C in skin tissue, using IT’IS database with tem-
perature-dependent perfusion. Our calculation shows that a
SARTDFL of 83W/kg is required to induce 4 C at the centre of
2.8 cm spherical target (equivalent to 10g of skin) using the
same tissue properties. The uncertainty of SARTDFL from simu-
lations was 23% in HT [7] and 42% in MRI [34] studies.
Therefore, the differences between the calculated vs. simu-
lated SAR values are less than the uncertainty of numerical
modelling (HT: 12% vs. 23% and MRI: 33% vs. 42%).
Guidelines to calculate SARTDFL
Finally, we provide a decision making flowchart that demon-
strates instructions to calculate the SARTDFL limit (Figure 5).
Hereto we first need to determine the size of target in a spe-
cific tissue which is estimated by the RF wavelength in a
lossy dielectric or tissue [35]. For hotspots with diameter
larger than 5 cm, the blood perfusion is the most influential
parameter. Therefore, thermal tissue properties under thermal
stress (e.g. ErasmusMC, Hyperplan and Lang databases)
should be used to calculate SARTDFL when the exposure dur-
ation is longer than 10min, and the thermoregulatory
response of tissue is activated [24,25]. This excludes hotspots
with a diameter less than 5 cm, since for small hotspots ther-
mal conductivity is the determinant parameter that has
similar values amongst the property databases. If the expos-
ure duration is shorter than 10min, we propose to use the
databases for basal/resting conditions (e.g. McIntosh and
IT’IS).
Discussion
The defined current limits for maximum human exposure to
RF EMF are conservative and incorporate large safety factors.
The limits are overly restrictive for some EMF based medical
applications such as HT and MRI in which increasing the lim-
its provides a better diagnosis or therapeutic effect.
Increasing the limits requires quantification of the incorpo-
rated safety factors which were originally selected based on
expert opinion rather than a rigorous quantitative process.
The main objective of the current study was to quantify the
incorporated safety factor in the current basic restrictions for
various local exposure scenarios. This was achieved by calcu-
lating the SARTDFL limits based on the lowest TDs that result
in local acute tissue damage, derived from our previous
study [9]. The calculated SARTDFL was analysed for various
target sizes, exposure durations and databases of thermal tis-
sue properties. Our results uncover the large safety factors
for muscle tissue between the SAR levels at which functional
changes occur (SARTDFL) and the current basic SAR restric-
tions (SARBR) (Table 3). The magnitude of the safety factor
ranged from 10.9 to 31.2 for psSAR10g. The lower and upper
bounds of the range were obtained for exposure durations
of 60 and 10min (10min¼ typical delay of the thermoregula-
tory process) using thermoregulated perfusion from the
Erasmus MC database, i.e. the reference database in this
study. Table 3 also shows the ratio between SARTDFL and MRI
guidelines (as an important guideline for an EMF-based med-
ical application).
The presented approach in the current study can be
extended to any tissue for which thermal threshold data is
available. Amongst the tissues studied (Table 1), we selected
muscle for three reasons, the common occurrence of thermal
hotspots upon medical applications of RF EMF, availability of
a wealth of data, and calculated SARTDFL limit being the low-
est among studied tissues (Figure 2).
The quoted results can be regarded as conservative esti-
mates since we employed the minimum value of the
reported CEM43 C doses amongst all available data for
humans and animal species. For instance, the lowest
CEM43 C dose for thermal damage in muscle has been
reported as 160min in dogs and 60min in pigs [36,37]. The
safety factor in Table 3 is calculated using the lower of these
values. In addition, functional changes in humans occur at
higher TDs due to much more efficient thermoregulatory sys-
tem in humans compared to animals [2]. Therefore, while
additional research on TDs in humans will be invaluable, we
believe that the incorporated safety factor for humans is
larger than the values shown in Table 3.
We also assessed the sensitivity of the calculated SARTDFL
to exposure parameters, i.e. the size of hotspot, exposure
duration and thermal tissue properties. Our results show
that the size of heated volume has a major impact on the
SARTDFL, i.e. the calculated SARTDFL increases rapidly with
Figure 5. Instructions to calculate SARTDFL limit. The outputs are SARTDFL limits
derived using basal or thermoregulated tissue properties.
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decreasing target diameter. The reason for this is the
increasing surface-to-volume ratio with decreasing target
diameter which leads to a stronger dissipation of the gener-
ated heat into surrounding tissue. In turn this leads to a
higher required SAR for inducing heating inside the target.
This finding is in line with the higher delivered SAR level
of deep HT treatment in the head and neck region (ca.
75W/kg) compared to pelvic region (ca. 16W/kg) which is
mainly due to smaller size of target in the head and neck
region [38,39]. This finding also confirms the relationship
between the SAR and tumour size in magnetic nanoparticle
HT reported previously [40]. Regarding the sensitivity of
results to exposure duration, we found that reduction of
exposure duration results in higher thresholds of safe tem-
perature-increase and consequently to a maximum of 10-
fold increase in SARTDFL (Figure 4). Finally, to assess sensitiv-
ity of the results to the tissue properties, we used various
available tissue property databases. The results show that
the impact of (delayed) temperature-regulated perfusion on
the SARTDFL is the most influential tissue parameter.
Therefore, more research on local thermoregulatory and tis-
sue damage processes is of high importance. In a target of
20 cm in muscle, thermoregulated perfusion increases
SARTDFL by up to 12.5-fold, compared to basal perfusion at
resting condition. In smaller heating volumes, where the
surface-to-volume ratio is big, perfusive effects are almost
non-existent, and thus thermal conductivity becomes the
primary mechanism of heat transport (Figure 3).
To validate our results, we compared the SAR limits for
two types of tissue (muscle and skin) as calculated in the cur-
rent study (SARTDFL) vs. the equivalent simulated value
(psSAR10g) from numerical calculations and experimental
investigations in HT and MRI applications. The comparison
shows that the calculated results in the current study are
consistent with the simulations and therefore, the SARTDFL
limits are valid.
Lastly, we should mention that the current study had a
number of assumptions. First, we assumed a constant tem-
perature over 60min of treatment. This is a conservative
approach (worst case) as heating is not expected to be either
spatially or temporally constant during the entire HT session.
In case of shorter exposure duration, the temperature and
also the calculated SAR will be higher according to the
CEM43 C definition (Equation (1). Second, for comparison of
SARTDFL among various tissues (Figure 2), we calculated
SARTDFL assuming that the target is uniformly heated. By this
simplification, the conduction term in PBE can be set to zero
and hence the PBE can be solved analytically. Third, no other
temperature related effects were considered, e.g. change of
SAR distribution due to thermoregulation dependent dielec-
tric parameter. Last, in this study, the perfusion is the micro-
scopic perfusion and the effect of macroscopic perfusion is
neglected, making our approach even more conservative
near major vessels.
Conclusions
The basis for the current basic restrictions, defined by ICNIRP
and IEEE, is to keep local tissue temperature rise under 1 C
for 30min of EMF exposure. However, thermal tissue damage
occurs at much higher TDs. In the current study, we explored
the actual safety margin that current guidelines provide in
preventing thermal tissue damage in various localised expos-
ure scenarios. Based on the available TD-effect data in litera-
ture, we calculated functional SAR limits (SARTDFL) and
consequently quantified the safety factor between SARTDFL
and the current basic restrictions (SARBR). We found that the
safety factor for the most common hotspot location, i.e.
muscle, is large: depending on the exposure duration
10.9–31.2. We concluded that the current basic restrictions
appear to be conservative and that functional limits and
application-specific modelling provide a valuable tool for tai-
loring the guidelines in specific applications.
The benefit of changing from generic to application-spe-
cific restrictions is that it facilitates a much better balance
between the need for the exposure, e.g. diagnostic or thera-
peutic, and the risk from thermal damage. Such an approach
might be beneficial for patients undergoing MRI to detect
abnormalities in anatomy, where higher quality imaging that
can yield better diagnoses would exceed current SAR safety
limits. Also in HT treatments, the functional limits may have
potential for balancing the probability of thermal toxicity
against probability of tumour control.
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Table 3. Safety factor between functional localised SAR limits (SARTDFL) in muscle and the basic restrictions on psSAR10g
a (SARBR) in the common generic guide-
lines [1,2] and also the restrictions on psSAR10g
a in the MRI guideline (SARMR) [8]. The lower and upper bounds of the range of safety factor were obtained for
exposure durations of 60 and 10min. The safety factor is valid over the same RF range that the basic restrictions are defined (100 kHz–3 GHz).
Safety factor
SARBR (W/kg): persons in
controlled environments
(ICNIRP, IEEE)
SARMR (W/kg): first level
controlled operation mode
(MRI guideline)
SARTDFL (W/kg):
(current study) (SARTDFL/SARBR) (SARTDFL/SARMR)
Head and trunk 10 20 218.4–312.3b 21.8–31.2 10.9–15.6
Extremities and ear pinnaec 20 40 218.4–312.3b 10.9–15.6 5.4–7.8
aPeak spatial SAR averaged over any 10 g of tissue.
bCalculated in a target (in shape of sphere) of 2.6 cm diameter, equivalent to 10 g of muscle.
cThe extremities are the arms and legs distal from the elbows and knees, respectively.
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